Arkema SA
LSE:0IB0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Arkema SA
LSE:0IB0
|
FR |
|
E
|
Energy Resources Of Australia Ltd
XBER:EJ7
|
AU |
|
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
|
US |
|
Viva Energy Group Ltd
F:2AH
|
AU |
|
D
|
Danske Bank A/S
SWB:DSN
|
DK |
Wall St Price Targets
0IB0 Price Targets Summary
Arkema SA
According to Wall Street analysts, the average 1-year price target for 0IB0 is 66.32 EUR with a low forecast of 51.68 EUR and a high forecast of 87.44 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0IB0's stock price target?
Price Target
66.32
EUR
According to Wall Street analysts, the average 1-year price target for 0IB0 is 66.32 EUR with a low forecast of 51.68 EUR and a high forecast of 87.44 EUR.
What is the Revenue forecast for Arkema SA?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 7 years is 3%.
What is the Operating Income forecast for Arkema SA?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Operating Income has been -4%. The projected CAGR for the next 5 years is 15%.
What is the Net Income forecast for Arkema SA?
Projected CAGR
71%
Over the last 13 years, the compound annual growth rate for Net Income has been -12%. The projected CAGR for the next 5 years is 71%.
